Sweating; Lymph mode pain in neck area of left side where injection given; Lymph node swelling in neck area of left side where injection given; Nausea; Fatigue; Fever 100.5; Injection site pain; Injection site Swelling; Injection site redness; Headache; Chills; Muscle pain; Sever joint pain all over body; This spontaneous case was reported by a non-health professional and describes the occurrence of HYPERHIDROSIS (Sweating), LYMPH NODE PAIN (Lymph mode pain in neck area of left side where injection given), VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE SWELLING (Injection site Swelling) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Diabetic on 01-Dec-2020, Hypertension on 01-Jan-2017 and Depression on 01-Jan-2012. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) from 01-Jan-2013 to an unknown date for Depression, METOPROLOL SUCCINATE (METOPROLOL [METOPROLOL SUCCINATE]) from 01-Jan-2013 to an unknown date for Hypertension.   On 09-Feb-2021 at 9:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021 at 9:20 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain), VACCINATION SITE SWELLING (Injection site Swelling), VACCINATION SITE ERYTHEMA (Injection site redness), HEADACHE (Headache), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Sever joint pain all over body), FATIGUE (Fatigue) and PYREXIA (Fever 100.5). On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), LYMPH NODE PAIN (Lymph mode pain in neck area of left side where injection given), LYMPHADENOPATHY (Lymph node swelling in neck area of left side where injection given) and NAUSEA (Nausea). On 12-Mar-2021, PYREXIA (Fever 100.5) had resolved. On 17-Mar-2021, VACCINATION SITE SWELLING (Injection site Swelling) and VACCINATION SITE ERYTHEMA (Injection site redness) outcome was unknown. On 27-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, HYPERHIDROSIS (Sweating), LYMPH NODE PAIN (Lymph mode pain in neck area of left side where injection given), VACCINATION SITE PAIN (Injection site pain), ARTHRALGIA (Sever joint pain all over body), LYMPHADENOPATHY (Lymph node swelling in neck area of left side where injection given), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown and CHILLS (Chills) and MYALGIA (Muscle pain) had resolved.            Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: ADR form has different case no. (MOD-2021-002330). All other available info in the form matches the existing info. New info - AE outcome and stop date, pt initials, etc - has been added. 1st dose was added Some Historical condition and Concomitant drug was added.